[ET Net News Agency, 29 December 2023] LEPU BIO-B (02157) rose 9% to HK$4.34, breaking
above the 100-D SMA of HK$4.254.
It hits an intra-day high of HK$4.4, hitting an 1-month high, and an intra-day low of
HK$4.04. The total shares traded was 3.73 million, with a value of HK$15.64m. The active
buy/sell ratio is 48:52, with net selling turnover of HK$494,070. CHINA INNOVATION MARKET
SER accounts for greatest net responsive buying turnover of HK$1.35m, with volume weighted
average price of HK$4.181. CHINA INV INFO accounts for greatest net responsive selling
turnover of HK$1.12m, with volume weighted average price of HK$4.208. The stock has risen
a combined 23.3% over the past 3 consecutive trading days.
Basic Information
=================
--------------------------------
Nominal 4.340 % Chg +9.05%
High 4.400 Low 4.040
Shares Tr 3.73m Turnover 15.64m
10-D SMA 3.745 %H.V 69.212
20-D SMA 3.581 VWAP 4.196
50-D SMA 3.746 RSI14 68.758
--------------------------------
Status: Breaking above the 100-D SMA, hitting an 1-month high, active buy/sell ratio is
48:52, with net selling turnover of HK$494,070, rising a combined 23.3% over the past 3
consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
LEPU BIO-B (02157) 4.34 +9.05
HUTCHMED (00013) 27.90 -0.71
FRONTAGE (01521) 2.26 +7.62
GENSCRIPT BIO (01548) 19.64 -0.71
INNOVENT BIO (01801) 42.50 +2.29
WUXI BIO (02269) 30.00 +3.81
TIGERMED (03347) 35.65 +1.28
BEIGENE (06160) 109.20 -1.00
AKESO (09926) 46.05 +1.54
REMEGEN (09995) 37.35 +2.19
---------------------------------------------
(ed)